| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A brief update on mass spectrometry applications to routine clinical endocrinology
|
Holmes, Daniel T.
|
|
2019
|
4-5 |
C |
p. 18-20
|
artikel
|
| 2 |
A fully automated high-throughput liquid chromatography tandem mass spectrometry method for measuring creatinine in urine
|
Zahoor, Neelam
|
|
|
4-5 |
C |
p. 1-7
|
artikel
|
| 3 |
Altered adrenal and gonadal steroids biosynthesis in patients with burn injury
|
Bergquist, Maria
|
|
2016
|
4-5 |
C |
p. 19-26
|
artikel
|
| 4 |
Analysis of 17 fentanyls in plasma and blood by UPLC-MS/MS with interpretation of findings in surgical and postmortem casework
|
Danaceau, Jonathan P.
|
|
|
4-5 |
C |
p. 38-47
|
artikel
|
| 5 |
Analysis of urinary VOCs using mass spectrometric methods to diagnose cancer: A review
|
da Costa, Bruno Ruiz Brandão
|
|
|
4-5 |
C |
p. 27-37
|
artikel
|
| 6 |
Analytical validation of protein biomarkers for risk of spontaneous preterm birth
|
Bradford, Chad
|
|
2017
|
4-5 |
C |
p. 25-38
|
artikel
|
| 7 |
An automated mass spectrometric blood test for therapeutic drug monitoring of infliximab
|
van der Gugten, J. Grace
|
|
2019
|
4-5 |
C |
p. 16-22
|
artikel
|
| 8 |
An isotope dilution LC–MS/MS-based candidate reference method for the quantification of androstenedione in human serum and plasma
|
Gradl, Katrin
|
|
|
4-5 |
C |
p. 1-10
|
artikel
|
| 9 |
Application of protein set enrichment analysis to correlation of protein functional sets with mass spectral features and multivariate proteomic tests
|
Grigorieva, Julia
|
|
|
4-5 |
C |
p. 44-53
|
artikel
|
| 10 |
Application of volumetric absorptive microsampling for robust, high-throughput mass spectrometric quantification of circulating protein biomarkers
|
van den Broek, Irene
|
|
2017
|
4-5 |
C |
p. 25-33
|
artikel
|
| 11 |
A proposal for score assignment to characterize biological processes from mass spectral analysis of serum
|
Roder, Joanna
|
|
|
4-5 |
C |
p. 13-26
|
artikel
|
| 12 |
A proposal to improve calibration and outlier detection in high-throughput mass spectrometry
|
Zabell, Adam P.R.
|
|
2016
|
4-5 |
C |
p. 25-33
|
artikel
|
| 13 |
A proposal to standardize the description of LC–MS-based measurement methods in laboratory medicine
|
Vogeser, Michael
|
|
2019
|
4-5 |
C |
p. 36-38
|
artikel
|
| 14 |
A sensitive method for the simultaneous UHPLC-MS/MS analysis of milrinone and dobutamine in blood plasma using NH4F as the eluent additive and ascorbic acid as a stabilizer
|
Takkis, Kalev
|
|
2019
|
4-5 |
C |
p. 23-29
|
artikel
|
| 15 |
A simplified, rapid LC-MS/MS assay for serum and salivary creatinine
|
Bernstone, Laura
|
|
|
4-5 |
C |
p. 21-26
|
artikel
|
| 16 |
Assessing a method and reference material for quantification of vitamin D binding protein during pregnancy
|
Kilpatrick, Lisa E.
|
|
|
4-5 |
C |
p. 11-17
|
artikel
|
| 17 |
Association of cystatin C proteoforms with estimated glomerular filtration rate
|
Trenchevska, Olgica
|
|
2016
|
4-5 |
C |
p. 27-31
|
artikel
|
| 18 |
A suggested standard for validation of LC-MS/MS based analytical series in diagnostic laboratories
|
Vogeser, Michael
|
|
|
4-5 |
C |
p. 25-32
|
artikel
|
| 19 |
A targeted proteomics approach to amyloidosis typing
|
Conti, Matteo
|
|
2018
|
4-5 |
C |
p. 18-28
|
artikel
|
| 20 |
A UHPLC–MS/MS method for the quantification of 7α-hydroxy-4-cholesten-3-one to assist in diagnosis of bile acid malabsorption
|
Prost, Jean-Christophe
|
|
2017
|
4-5 |
C |
p. 1-6
|
artikel
|
| 21 |
Averaging of results derived from different, simultaneously acquired mass transitions in ID-LC-MS/MS – Potential impact on measurement imprecision
|
Schuster, Carina
|
|
|
4-5 |
C |
p. 1-3
|
artikel
|
| 22 |
Bias due to isotopic incorporation in both relative and absolute protein quantitation with carbon-13 and nitrogen-15 labeled peptides
|
Rappold, Brian A.
|
|
2017
|
4-5 |
C |
p. 13-21
|
artikel
|
| 23 |
Building a foundation for clinical mass spectrometry and improved patient standard-of-care
|
Herold, David
|
|
2016
|
4-5 |
C |
p. 1
|
artikel
|
| 24 |
Clinically-relevant Shiga toxin 2 subtypes from environmental Shiga toxin-producing Escherichia coli identified by top-down/middle-down proteomics and DNA sequencing
|
Fagerquist, Clifton K.
|
|
|
4-5 |
C |
p. 27-36
|
artikel
|
| 25 |
Clinical Mass Spectrometry – Call for Papers
|
Rockwood, Alan L.
|
|
2016
|
4-5 |
C |
p. 2
|
artikel
|
| 26 |
Collision energy-breakdown curves – An additional tool to characterize MS/MS methods
|
Mörlein, Sophie
|
|
|
4-5 |
C |
p. 48-53
|
artikel
|
| 27 |
Comparative metabolite profiling of a metastatic and primary melanoma cell line using untargeted metabolomics: A case study
|
Yu, Zhihao
|
|
2018
|
4-5 |
C |
p. 16-24
|
artikel
|
| 28 |
Comparison of four clinically validated testosterone LC-MS/MS assays: Harmonization is an attainable goal
|
French, Deborah
|
|
|
4-5 |
C |
p. 12-20
|
artikel
|
| 29 |
Corrigendum to “Manipulating trypsin digestion conditions to accelerate proteolysis and simplify digestion workflows in development of protein mass spectrometric assays for the clinical laboratory” [Clin. Mass Spectrom. 6C (2018) 1–12]
|
Zheng, Yu Zi
|
|
2018
|
4-5 |
C |
p. 33-34
|
artikel
|
| 30 |
Could severe burn be a cause of male infertility?
|
Amin, Ali
|
|
2017
|
4-5 |
C |
p. 39-40
|
artikel
|
| 31 |
Data analysis of MS-based clinical lipidomics studies with crossover design: A tutorial mini-review of statistical methods
|
Zhao, Xueheng
|
|
2019
|
4-5 |
C |
p. 5-17
|
artikel
|
| 32 |
Detection of drugs of abuse in urine using the Bruker Toxtyper™: Experiences in a routine clinical laboratory setting
|
Ott, M.
|
|
2017
|
4-5 |
C |
p. 11-18
|
artikel
|
| 33 |
Determination of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis by MALDI-TOF MS in clinical isolates from Latvia
|
Alksne, Laura
|
|
|
4-5 |
C |
p. 33-39
|
artikel
|
| 34 |
Determination of nucleosidic/tidic reverse transcriptase inhibitors in plasma and cerebrospinal fluid by ultra-high-pressure liquid chromatography coupled with tandem mass spectrometry
|
Courlet, Perrine
|
|
2018
|
4-5 |
C |
p. 8-20
|
artikel
|
| 35 |
Determining histone H4 acetylation patterns in human peripheral blood mononuclear cells using mass spectrometry
|
Bux, Esther Marie
|
|
|
4-5 |
C |
p. 54-60
|
artikel
|
| 36 |
Development and evaluation of matrix application techniques for high throughput mass spectrometry imaging of tissues in the clinic
|
Huizing, Lennart R.S.
|
|
2019
|
4-5 |
C |
p. 7-15
|
artikel
|
| 37 |
Development and validation of a liquid chromatography-tandem mass spectrometry method for determination of ibuprofen in human plasma
|
Puangpetch, Apichaya
|
|
|
4-5 |
C |
p. 6-12
|
artikel
|
| 38 |
Development and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous determination of phthalates and bisphenol a in serum, urine and follicular fluid
|
Pia Dima, Anna
|
|
|
4-5 |
C |
p. 54-65
|
artikel
|
| 39 |
Development of a CDC-certified total testosterone assay for adult and pediatric samples using LC–MS/MS
|
Star-Weinstock, Michal
|
|
2019
|
4-5 |
C |
p. 27-35
|
artikel
|
| 40 |
Development of a LC-MS/MS method for urinary hydroxytyrosol as a marker for consumption of olive oil
|
Johnson, Lisa M.
|
|
|
4-5 |
C |
p. 1-5
|
artikel
|
| 41 |
Development of a prototype blood fractionation cartridge for plasma analysis by paper spray mass spectrometry
|
Bills, Brandon J.
|
|
2016
|
4-5 |
C |
p. 18-24
|
artikel
|
| 42 |
Development of dried blood spot quality control materials for adenosine deaminase severe combined immunodeficiency and an LC-MS/MS method for their characterization
|
Young, Brian
|
|
|
4-5 |
C |
p. 4-11
|
artikel
|
| 43 |
Diagnosis and the importance of early treatment of tyrosinemia type 1: A case report
|
Škaričić, Ana
|
|
2019
|
4-5 |
C |
p. 1-6
|
artikel
|
| 44 |
Dilute, derivatise and shoot: Measurement of urinary free metanephrines and catecholamines as ethyl derivatives by LC-MSMS
|
Ellis, Andrew G.
|
|
2017
|
4-5 |
C |
p. 34-41
|
artikel
|
| 45 |
Direct detection of intact Klebsiella pneumoniae carbapenemase variants from cell lysates: Identification, characterization and clinical implications
|
McGee, William M.
|
|
|
4-5 |
C |
p. 12-21
|
artikel
|
| 46 |
Establishment and verification of chromium and cobalt concentrations in joint fluids from a reference population
|
Haglock-Adler, Carrie J.
|
|
|
4-5 |
C |
p. 32-35
|
artikel
|
| 47 |
Evaluation of a multiplex liquid chromatography-tandem mass spectrometry method for congenital adrenal hyperplasia in pediatric patients
|
Cao, Jing
|
|
2018
|
4-5 |
C |
p. 18-22
|
artikel
|
| 48 |
Evaluation of a one-step sample preparation protocol for analysis of total serum testosterone by LC–MS/MS
|
Ke, Yuyong
|
|
2018
|
4-5 |
C |
p. 9-15
|
artikel
|
| 49 |
11β-Hydroxylase deficiency detected by urine steroid metabolome profiling using gas chromatography-mass spectrometry
|
Tran, Mai Thi Chi
|
|
2018
|
4-5 |
C |
p. 1-5
|
artikel
|
| 50 |
Identification of potential endometriosis biomarkers in peritoneal fluid and blood plasma via shotgun lipidomics
|
Starodubtseva, Natalia
|
|
2019
|
4-5 |
C |
p. 21-26
|
artikel
|
| 51 |
Improvement of drug identification in urine by LC-QqTOF using a probability-based library search algorithm
|
Colby, Jennifer M.
|
|
2017
|
4-5 |
C |
p. 7-12
|
artikel
|
| 52 |
Instability of 7-aminoclonazepam in frozen storage conditions
|
Dahlin, Jayme L.
|
|
2018
|
4-5 |
C |
p. 23-24
|
artikel
|
| 53 |
LC–MS/MS application for urine free pyridinoline and free deoxypyridinoline: Urine markers of collagen and bone degradation
|
Tang, Jonathan C.Y.
|
|
2016
|
4-5 |
C |
p. 11-18
|
artikel
|
| 54 |
LC–MS/MS method for quantitation of mycophenolic acid, mycophenolic acid acyl-glucuronide, and 7-O-mycophenolic acid glucuronide in serum
|
Merrigan, Stephen D.
|
|
2017
|
4-5 |
C |
p. 41-48
|
artikel
|
| 55 |
Lipidomic profiling of plasma in a healthy Singaporean population to identify ethnic specific differences in lipid levels and associations with disease risk factors
|
Begum, Husna
|
|
|
4-5 |
C |
p. 25-31
|
artikel
|
| 56 |
Long-term stability of the alcohol consumption biomarker phosphatidylethanol in erythrocytes at −80 °C
|
Lakso, Hans-Åke
|
|
|
4-5 |
C |
p. 37-41
|
artikel
|
| 57 |
MALDI-MS: Emerging roles in pathology and laboratory medicine
|
Duncan, Mark
|
|
2019
|
4-5 |
C |
p. 1-4
|
artikel
|
| 58 |
Manipulating trypsin digestion conditions to accelerate proteolysis and simplify digestion workflows in development of protein mass spectrometric assays for the clinical laboratory
|
Zheng, Yu Zi
|
|
|
4-5 |
C |
p. 1-12
|
artikel
|
| 59 |
Mass spectrometry in clinical glycomics: The path from biomarker identification to clinical implementation
|
de Haan, N.
|
|
|
4-5 |
C |
p. 1-12
|
artikel
|
| 60 |
Measurement of 2-hydroxyglutarate enantiomers in serum by chiral gas chromatography-tandem mass spectrometry and its application as a biomarker for IDH mutant gliomas
|
Strain, Shinji K.
|
|
|
4-5 |
C |
p. 16-24
|
artikel
|
| 61 |
Medical mass spectrometrist (MMS) training and certification: A key step to expanding routine clinical mass spectrometry usage in Japan
|
Nomura, Fumio
|
|
|
4-5 |
C |
p. 13-15
|
artikel
|
| 62 |
Migration from RIA to LC-MS/MS for aldosterone determination: Implications for clinical practice and determination of plasma and urine reference range intervals in a cohort of healthy Belgian subjects
|
Le Goff, Caroline M.
|
|
2018
|
4-5 |
C |
p. 7-17
|
artikel
|
| 63 |
More sensitivity is always better: Measuring sub-clinical levels of serum thyroglobulin on a µLC–MS/MS system
|
Shuford, Christopher M.
|
|
|
4-5 |
C |
p. 29-35
|
artikel
|
| 64 |
Multiplexed analysis of steroid hormones in saliva by LC-MS/MS with 2-hydrazinopyridine derivatization
|
Nadarajah, Nirosa
|
|
2017
|
4-5 |
C |
p. 1-10
|
artikel
|
| 65 |
Multiplexed therapeutic drug monitoring (TDM) of antiviral drugs by LC–MS/MS
|
Conti, M.
|
|
2018
|
4-5 |
C |
p. 6-17
|
artikel
|
| 66 |
Observation of a positive interference in LC-MS/MS measurement of d6-25-OH-vitamin D3
|
Fortuna, Danielle
|
|
2017
|
4-5 |
C |
p. 22-24
|
artikel
|
| 67 |
Phenotyping of α-1-Antitrypsin by liquid chromatography–high resolution mass spectrometry
|
Bengtson, Per
|
|
2016
|
4-5 |
C |
p. 34-40
|
artikel
|
| 68 |
Quantification of volatile metabolites in exhaled breath by selected ion flow tube mass spectrometry, SIFT-MS
|
Španěl, Patrik
|
|
|
4-5 |
C |
p. 18-24
|
artikel
|
| 69 |
Quantitation of total fatty acids in plasma and serum by GC-NCI-MS
|
Kish-Trier, E.
|
|
2016
|
4-5 |
C |
p. 11-17
|
artikel
|
| 70 |
Rapid method towards proteomic analysis of dried blood spots by MALDI mass spectrometry
|
Samenuk, Grace M.
|
|
2019
|
4-5 |
C |
p. 30-36
|
artikel
|
| 71 |
Rapid screening and identification of novel psychoactive substances using PaperSpray interfaced to high resolution mass spectrometry
|
Kennedy, Joseph
|
|
2016
|
4-5 |
C |
p. 3-10
|
artikel
|
| 72 |
Real-time mass spectrometric identification of metabolites characteristic of chronic obstructive pulmonary disease in exhaled breath
|
Bregy, Lukas
|
|
2018
|
4-5 |
C |
p. 29-35
|
artikel
|
| 73 |
Reproducibility assessment for a broad spectrum drug screening method from urine using liquid chromatography time-of-flight mass spectrometry
|
Metushi, Imir G.
|
|
2018
|
4-5 |
C |
p. 1-7
|
artikel
|
| 74 |
RETRACTED: Identification of metabolites of brexpiprazole in human urine for use in monitoring patient compliance
|
Enders, Jeffrey R.
|
|
|
4-5 |
C |
p. 21-24
|
artikel
|
| 75 |
Role of mass spectrometry in establishing safety and efficacy of botanical dietary supplements
|
van Breemen, Richard B.
|
|
|
4-5 |
C |
p. 25-28
|
artikel
|
| 76 |
Screening for adiponectin receptor agonists and their metabolites in urine and dried blood spots
|
Dib, Josef
|
|
|
4-5 |
C |
p. 13-20
|
artikel
|
| 77 |
Simultaneous measurement of 18 steroids in human and mouse serum by liquid chromatography–mass spectrometry without derivatization to profile the classical and alternate pathways of androgen synthesis and metabolism
|
Desai, Reena
|
|
|
4-5 |
C |
p. 42-51
|
artikel
|
| 78 |
SPE-IMS-MS: An automated platform for sub-sixty second surveillance of endogenous metabolites and xenobiotics in biofluids
|
Zhang, Xing
|
|
2016
|
4-5 |
C |
p. 1-10
|
artikel
|
| 79 |
Subtyping of hepatitis C virus with high resolution mass spectrometry
|
Uddin, Reaz
|
|
2017
|
4-5 |
C |
p. 19-24
|
artikel
|
| 80 |
Tandem mass spectrometry in the clinical laboratory: A tutorial overview
|
van der Gugten, J. Grace
|
|
|
4-5 |
C |
p. 36-43
|
artikel
|
| 81 |
The importance of clinical tissue imaging
|
Spraggins, Jeffrey M.
|
|
2019
|
4-5 |
C |
p. 47-49
|
artikel
|
| 82 |
Thyrotoxicosis due to 1000-fold error in compounded liothyronine: A case elucidated by mass spectrometry
|
Khan, Wajid
|
|
|
4-5 |
C |
p. 8-11
|
artikel
|
| 83 |
Understanding the strategic landscape surrounding the implementation of mass spectrometry in the clinical laboratory: A SWOT analysis
|
Vogeser, Michael
|
|
2018
|
4-5 |
C |
p. 1-6
|
artikel
|
| 84 |
Unified representation of high- and low-resolution spectra to facilitate application of mass spectrometric techniques in clinical practice
|
Zhvansky, E.S.
|
|
2019
|
4-5 |
C |
p. 37-46
|
artikel
|
| 85 |
Urine analysis of 28 designer benzodiazepines by liquid chromatography–high-resolution mass spectrometry
|
Pettersson Bergstrand, Madeleine
|
|
2018
|
4-5 |
C |
p. 25-32
|
artikel
|
| 86 |
Volumetric absorptive microsampling (VAMS) coupled with high-resolution, accurate-mass (HRAM) mass spectrometry as a simplified alternative to dried blood spot (DBS) analysis for therapeutic drug monitoring of cardiovascular drugs
|
Tanna, Sangeeta
|
|
2018
|
4-5 |
C |
p. 1-8
|
artikel
|
Tijdschrift beschrijving